ResearcherUniversity of ArizonaActive in the last 2 years

Natalia A. Ignatenko

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8096-1340; OpenAlex author ID A5016178832. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hwudaurw Chen · 2 shared papers, 2015–2026 · strength 0.45
- Paper Difluoromethylornithine modulates mutant K-RAS signaling pathways in pancreatic cancer cells. DOI 10.1007/s00726-026-03559-5 ↗
- Paper Mutant K-RAS Promotes Invasion and Metastasis in Pancreatic Cancer Through GTPase Signaling Pathways. DOI 10.4137/cgm.s29407 ↗
Eugene W. Gerner · 1 shared paper, 2026 · strength 0.39
- Paper Difluoromethylornithine modulates mutant K-RAS signaling pathways in pancreatic cancer cells. DOI 10.1007/s00726-026-03559-5 ↗
Julianna Padavano · 1 shared paper, 2015 · strength 0.06
- Paper Mutant K-RAS Promotes Invasion and Metastasis in Pancreatic Cancer Through GTPase Signaling Pathways. DOI 10.4137/cgm.s29407 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.